Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Appointment Request
Blocked Timeslot
Restricted Timeslot
Exhibitor List
|
Actelion Pharmaceuticals US, Inc. |
9015 |
|
|
|
| | | |
|
Akcea Therapeutics |
2017 |
|
|
|
| | | |
|
Akcea Therapeutics |
ES18099 |
|
|
|
| | | |
|
Alnylam Pharmaceuticals, Inc. |
7085 |
 |
|
|
| | | |
|
Alnylam Pharmaceuticals, Inc. |
ES7103 |
|
|
|
| | | |
|
Alnylam Pharmaceuticals, Inc. |
ES8102 |
|
|
|
| | | |
|
Amarin Pharma Inc. |
2041 |
|
|
|
|  |  |  |
|
Amarin Pharma Inc. |
ES5103 |
|
|
|
| | | |
|
Amgen |
5025 |
|
|
|
| | | |
|
Amgen |
10029 |
|
|
|
| | | |
|
Amgen |
ES11028 |
|
|
|
| | | |
|
Amryt Pharma |
2050 |
|
|
|
| | | |
|
ANI Pharmaceuticals, Inc. |
21073 |
|
|
|
| | | |
|
AstraZeneca |
5063 |
|
|
|
| | | |
|
AstraZeneca |
ES7098 |
|
|
|
| | | |
|
AstraZeneca |
ES7100 |
|
|
|
| | | |
|
AstraZeneca |
ES7104 |
|
|
|
| | | |
|
AstraZeneca |
ES7099 |
|
|
|
| | | |
|
AstraZeneca |
ES7101 |
|
|
|
| | | |
|
Bayer Healthcare Pharmaceuticals |
22076 |
|
|
|
| | | |
|
BMS/Pfizer |
ES8101 |
|
|
|
| | | |
|
BMS/Pfizer |
8062 |
|
|
 |
| | | |
|
Boehringer Ingelheim Pharmaceuticals, Inc. |
13008 |
|
|
|
| | | |
|
Boehringer Ingelheim Pharmaceuticals, Inc. |
ES12026 |
|
|
|
| | | |
|
BridgeBio Pharma, Inc. |
19075 |
|
|
|
| | | |
|
Cell>Point, LLC |
8055 |
|
|
|
| | | |
|
CMP Pharma |
12003 |
|
|
|
| | | |
|
Cytokinetics, Inc. |
7039 |
|
|
|
| | | |
|
Denka Seiken Co., Ltd. |
1016 |
|
|
|
| | | |
|
Esperion Therapeutics, Inc. |
11020 |
|
|
|
| | | |
|
Janssen Pharmaceuticals, Inc. |
7009 |
|
|
|
| | | |
|
Janssen Scientific Affairs, LLC |
ES11029 |
|
|
|
| | | |
|
Janssen Scientific Affairs, LLC |
1054 |
|
|
|
| | | |
|
Janssen Scientific Affairs, LLC |
ES11031 |
|
|
|
| | | |
|
Johnson & Johnson |
FH1 |
|
|
|
| | | |
|
Kiniksa Pharmaceuticals |
ES8098 |
|
|
|
| | | |
|
Kiniksa Pharmaceuticals |
7049 |
|
|
|
| | | |
|
Lundbeck, Inc. |
9005 |
|
|
|
| | | |
|
Medicure Inc. |
21011 |
|
|
|
| | | |
|
Merck |
ES25099 |
|
|
|
| | | |
|
Merck |
ES12030 |
|
|
|
| | | |
|
Merck & Co., Inc. |
3084 |
|
|
|
| | | |
|
Merck & Co., Inc. |
3085 |
|
|
|
| | | |
|
Merck & Co., Inc. |
ES10010 |
|
|
|
| | | |
|
MyoKardia Inc. |
ES9097 |
|
|
|
| | | |
|
MyoKardia Inc. |
2055 |
|
|
|
| | | |
|
MyoKardia Inc. |
FH9 |
|
|
|
| | | |
|
Novartis Pharmaceuticals Corporation |
8083 |
|
|
|
| | | |
|
Novartis Pharmaceuticals Corporation |
5045 |
|
|
|
| | | |
|
Novartis Pharmaceuticals Corporation |
5099 |
|
|
|
| | | |
|
Novartis Pharmaceuticals Corporation |
FH3 |
|
|
|
| | | |
|
Novo Nordisk, Inc. |
9054 |
|
|
|
| | | |
|
Organicell |
19069 |
|
|
|
| | | |
|
Pfizer |
5073 |
|
|
|
| | | |
|
Pfizer, Inc. |
ES10012 |
|
|
|
| | | |
|
Pharma Nord, Inc. |
15095 |
|
|
|
| | | |
|
PhaseBio Pharmaceuticals, Inc. |
8024 |
|
|
|
| | | |
|
PhaseBio Pharmaceuticals, Inc. |
ES6105 |
|
|
|
| | | |
|
PLx Pharma, Inc. |
20075 |
|
|
|
| | | |
|
Portola Pharmaceuticals |
3079 |
|
|
|
| | | |
|
Portola Pharmaceuticals |
ES5098 |
|
|
|
| | | |
|
Sarfez Pharmaceuticals |
9042 |
|
|
|
| | | |
|
scPharmaceuticals |
8088 |
|
|
|
| | | |
|
Valisure |
22050 |
|
|
|
| | | |